{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:22:56Z","timestamp":1790706176403,"version":"4.1.0"},"reference-count":69,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Imaging biomarkers are essential in Alzheimer's disease (AD) diagnosis, particularly since the introduction of the ATN criteria by the NIA-AA. These criteria include amyloid-\u03b2 plaques (amyloid PET), fibrillar tau (tau PET), and neurodegeneration (FDG PET or MRI). Early-phase amyloid PET imaging has shown a strong correlation with FDG PET at the group level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluates the comparability of early-phase FBB PET (eFBB) perfusion imaging and FDG PET metabolic imaging at both group and individual levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective study included 103 patients with mild cognitive impairment (MCI) or mild dementia suspected of AD who underwent FDG PET and dual-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-Florbetaben PET (including a 5-min eFBB scan) between 2019 and 2023, along with 33 healthy controls. Imaging analyses included qualitative, semi-quantitative, and voxel-wise techniques to compare eFBB and FDG PET scans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>eFBB and FDG PET SUVR values showed a strong correlation across all brain regions (rho\u2009=\u20090.879). Visual assessments of eFBB and FDG PET by two raters achieved intra-observer agreement rates of 87.5% and 86.4%, respectively. Voxel-wise analysis revealed moderate to good overlap, as indicated by Dice-S\u00f8rensen coefficients, in the MCI and mild dementia groups. Discriminative performance between eFBB and FDG PET was comparable, with no significant differences as eFBB reliably reflected brain metabolic patterns observed on FDG PET, supporting its diagnostic utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>eFBB PET could serve as a surrogate biomarker for FDG PET in the diagnostic evaluation of neurodegenerative dementias. Dual-phase amyloid PET enables simultaneous assessment of neurodegeneration and amyloid burden, offering a streamlined and resource-efficient approach for clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877251340380","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:11:07Z","timestamp":1746756667000},"page":"304-316","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of early-phase\n                    <sup>18<\/sup>\n                    F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with\n                    <sup>18<\/sup>\n                    F-FDG PET at group and single patient level"],"prefix":"10.1177","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-8250","authenticated-orcid":false,"given":"Jose Antonio","family":"Lojo-Ram\u00edrez","sequence":"first","affiliation":[{"name":"Instituto de Biomedicina de Sevilla, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Espa\u00f1a"},{"name":"Servicio de Medicina Nuclear, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Espa\u00f1a"},{"name":"Servicio de Medicina Nuclear, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Guerra-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Espa\u00f1a"},{"name":"Servicio de Medicina Nuclear, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Marta","family":"Mar\u00edn-Caba\u00f1as","sequence":"additional","affiliation":[{"name":"Unidad de Memoria, Servicio de Neurolog\u00eda, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-1037","authenticated-orcid":false,"given":"Emilio","family":"Franco-Mac\u00edas","sequence":"additional","affiliation":[{"name":"Unidad de Memoria, Servicio de Neurolog\u00eda, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Jim\u00e9nez-Hoyuela-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Espa\u00f1a"},{"name":"Servicio de Medicina Nuclear, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garc\u00eda-Sol\u00eds","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Espa\u00f1a"},{"name":"Servicio de Medicina Nuclear, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0909142"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1042\/bss0670081"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.10.007"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.063305"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70001-2"},{"key":"e_1_3_4_13_2","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging","volume":"45","author":"Silverman DH","year":"2004","unstructured":"Silverman DH. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004; 45: 594\u2013607.","journal-title":"J Nucl Med"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.10900"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25442"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf185"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266273"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3393-6"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00070"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002768"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3353-1"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/s21155182"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.083683"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.082057"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X16645593"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2016.10.005"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.05.010"},{"key":"e_1_3_4_28_2","article-title":"Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer\u2019s disease PET studies","volume":"14","author":"Peretti DE","year":"2019","unstructured":"Peretti DE, Garc\u0131a DV, Reesink FE, et al. Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer\u2019s disease PET studies. PLoS One 2019; 14: e0211000.","journal-title":"PLoS One"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102750"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.11.006"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-2051-2"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.661284"},{"key":"e_1_3_4_33_2","first-page":"211","article-title":"Static first-minute-frame (FMF) PET imaging after 18F-labeled amyloid tracer injection is correlated to [18F]FDG PET in patients with primary progressive aphasia","volume":"42","author":"G\u00f3mez-Grande A","year":"2023","unstructured":"G\u00f3mez-Grande A, Seiffert AP, Villarejo-Galende A, et al. Static first-minute-frame (FMF) PET imaging after 18F-labeled amyloid tracer injection is correlated to [18F]FDG PET in patients with primary progressive aphasia. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2023; 42: 211\u2013217.","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-021-00123-0"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2017.03.003"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264256"},{"key":"e_1_3_4_37_2","unstructured":"Annen J Sala A Bonin EA et al. FDG-PET\/CT data of healthy volunteers and patients with disorders of consciousness [dataset]. EBRAINS; 2021. Available from: https:\/\/ebrains.eu\/resources."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/1533317517722630"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210115"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191235"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1136"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2017.09.124"},{"key":"e_1_3_4_45_2","unstructured":"GE Healthcare. Cortex ID (version 3.2) [computer software]. GE Healthcare; 2024. Available from: https:\/\/www.gehealthcare.com."},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420114"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1194-1"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.17.2120"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045385"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2007.09.020"},{"key":"e_1_3_4_51_2","first-page":"1238","article-title":"A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima S","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238\u20131248.","journal-title":"J Nucl Med"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.11.026"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2014.12.004"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23291"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.214270"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70077-1"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-8119(09)70884-5"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.02.004"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3749-6"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161927"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.09.001"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00807-6"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118775"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2014.10.009"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.185835"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.07.002"},{"key":"e_1_3_4_68_2","unstructured":"Jamovi project. Jamovi. (Version 2.5) [Computer Software]. The Jamovi Project; 2024. Available from: https:\/\/www.jamovi.org."},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251340380","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877251340380","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251340380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:40Z","timestamp":1777371040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877251340380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/13872877251340380"],"URL":"https:\/\/doi.org\/10.1177\/13872877251340380","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]}}}